NCT03686644

Brief Summary

Children with cerebral palsy present early in the childhood altered muscular properties, characterized by short muscle belly length and increased stiffness which contribute to contracture and limiting joint range of motion. In order to prevent equinus deformity, ankle foot orthoses for night splinting are usually used in children with spastic Cerebral Palsy (CP). However, there's a lack of proof about efficacy by using this modality of treatment. Moreover, impact on quality of life for children and families, cost for society were high. Principal purpose of this study was to assess impact of night splint ankle foot orthoses on passive stiffness in plantarflexors muscles in children with CP.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2018

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 27, 2018

Completed
19 days until next milestone

Study Start

First participant enrolled

October 16, 2018

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2018

Completed
Last Updated

July 22, 2022

Status Verified

July 1, 2022

Enrollment Period

Same day

First QC Date

September 24, 2018

Last Update Submit

July 19, 2022

Conditions

Keywords

night splintingstiffnessankle foot orthosesteenager

Outcome Measures

Primary Outcomes (1)

  • change from baseline elasticity modulus of the leg muscles at 4 weeks

    measured by ultrasounds

    Weeks 0, 1, 2, 3 and 4

Secondary Outcomes (4)

  • Maximal dorsiflexion angle

    Weeks 0, 1, 2, 3 and 4

  • Maximum angle of tense knee dorsiflexion

    Weeks 0, 1, 2, 3 and 4

  • Torque of force maximal tolerated in maximum angle of tense knee dorsiflexion

    Weeks 0, 1, 2, 3 and 4

  • Visual Analog Scale of sleeping

    Weeks 0, 1, 2, 3 and 4

Study Arms (1)

Children with Cerebral Palsy

EXPERIMENTAL

Children with Cerebral Palsy (CP) will be included. They will have to wearing of night splint ankle foot orthoses (phase A) and then no wearing of night splint ankle foot orthoses (phase B). The phases A and B will be repeated twice. In more, they will have an ultrasound, isokinetic dynamometer and measure of quality of night sleeping.

Procedure: Wearing of night splint ankle foot orthoses (phase A)Procedure: No wearing of night splint ankle foot orthoses (phase B)

Interventions

Children wearing of night splint ankle foot orthoses during 6, 7 or 8 days according to the position of inclusion. An ultrasound of the leg muscles will be realized every morning after removing night splint. An isokinetic dynamometer will be realize at the beginning of the study and at the end of each phase. measure of quality of night sleeping will be measured by Visual Analog Scale (VAS) results.

Children with Cerebral Palsy

Children no wearing of night splint ankle foot orthoses during 6, 7 or 8 days according to the position of inclusion. An ultrasound of the leg muscles will be realized every morning after removing night splint. An isokinetic dynamometer will be realize at the beginning of the study and at the end of each phase. measure of quality of night sleeping will be measured by Visual Analog Scale (VAS) results.

Children with Cerebral Palsy

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children diagnosed spastic cerebral palsy
  • Children wearing night splint ankle foot orthoses all night long during 1 week minimum
  • Children with a level of spasticity in the gastrocnemius muscle greater than or equal to X1, VII, on the Tardieu scale and 2 on the Ashworth scale.
  • Children able to understand and respect the simple instructions of the study
  • Children and parents who received informed information about the study and who co-signed, with the investigator, a consent to participate in the study.

You may not qualify if:

  • Children who do not tolerate ankle foot orthoses all night long.
  • Children who had botulinum injection in gastrocnemius or soleus muscles during last three months.
  • Children benefiting from an injection of botulinum toxin or the setting up of new equipment during the protocol.
  • Children who do not tolerate ankle foot orthoses all night long.
  • Children having benefited from plaster lengthening for less than three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Vincent GAUTHERON, MD PhD

    CHU de Saint Etienne

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 24, 2018

First Posted

September 27, 2018

Study Start

October 16, 2018

Primary Completion

October 16, 2018

Study Completion

October 16, 2018

Last Updated

July 22, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share